Back to mobile site

More on CING

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cingulate Inc (NQ:CING)
Delayed: 4.84 -0.05 (1.02%)
Prev. Close $4.89  
Open$4.81 
52 Wk High$ 
52 Wk Low$ 
Day High$4.89 
Day Low$4.81 
P/E N/A  
EPS$ 
Volume17,144 

Friends, Peers and Foes (?): CINGW (more...)

Oct 2, 2026 05:01 PM Form 4 Cingulate Inc. For: Sep 30 Filed by: Silva Raul R.
Oct 2, 2026 04:31 PM Form 8-K Cingulate Inc. For: Sep 30
Sep 17, 2026 08:05 AM Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Aug 13, 2026 08:46 AM Form 10-Q Cingulate Inc. For: Jun 30
Aug 13, 2026 08:40 AM Form 8-K Cingulate Inc. For: Aug 13
Aug 13, 2026 08:31 AM Cingulate posts wider Q2 loss as SG&A spending more than doubles
Aug 13, 2026 08:30 AM Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Aug 11, 2026 08:31 AM Cingulate publishes PK data for ADHD drug CTx-1301 in CNS Drugs
Aug 11, 2026 08:30 AM Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Jul 30, 2026 08:30 AM Cingulate publishes phase 3 ADHD drug trial results in peer-reviewed journal
View All Articles

Entities mentioned with CING

View All Entities